Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
6.88
+0.12 (1.78%)
At close: Aug 13, 2025, 4:00 PM
6.75
-0.13 (-1.89%)
After-hours: Aug 13, 2025, 7:12 PM EDT

G1 Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
7653321,010639958-
Upgrade
Market Cap Growth
-39.46%-67.13%57.94%-33.25%--
Upgrade
Enterprise Value
62076689287461-
Upgrade
Last Close Price
6.883.099.907.2510.9411.44
Upgrade
PS Ratio
31.197.8927.6425.7225.86-
Upgrade
PB Ratio
5.651.663.992.562.78-
Upgrade
P/TBV Ratio
5.671.663.992.562.78-
Upgrade
EV/Sales Ratio
25.511.8118.8711.5312.45-
Upgrade
Debt / Equity Ratio
0.260.180.150.170.000.20
Upgrade
Debt / FCF Ratio
-----0.11
Upgrade
Asset Turnover
0.080.120.090.050.110.06
Upgrade
Quick Ratio
4.526.767.336.6311.984.70
Upgrade
Current Ratio
4.756.987.546.7612.104.73
Upgrade
Return on Equity (ROE)
-76.09%-57.58%-40.49%-36.41%-30.38%-223.51%
Upgrade
Return on Assets (ROA)
-31.74%-25.31%-17.01%-14.82%-10.28%-24.81%
Upgrade
Return on Capital (ROIC)
-43.16%-34.47%-24.50%-21.80%-18.52%-103.69%
Upgrade
Earnings Yield
-19.02%-39.26%-10.08%-16.92%-6.08%-
Upgrade
FCF Yield
-19.49%-39.85%-11.84%-18.27%-6.41%-
Upgrade
Buyback Yield / Dilution
-5.10%-15.50%-7.69%-41.40%-94.50%-255.37%
Upgrade
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q